Vetera EHVXP 1/4This page contains information on Vetera EHVXP 1/4 for veterinary use.
The information provided typically includes the following:
- Vetera EHVXP 1/4 Indications
- Warnings and cautions for Vetera EHVXP 1/4
- Direction and dosage information for Vetera EHVXP 1/4
Vetera EHVXP 1/4This treatment applies to the following species:
Equine Rhinopneumonitis Vaccine
Vetera EHVXP 1/4 Indications
This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against respiratory disease due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4). The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.
Directions and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.
PrecautionsStore at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
Preservatives: Amphotericin B and gentamicin.
For use in animals only
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
© 2019 Boehringer Ingelheim Animal Health USA Inc. All rights reserved.
US Patent Nos. 6,803,041 and 7,226,604.
Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506
Phone: 1 (888) 637-4251
10 Doses/10 mL
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Copyright © 2023 Animalytix LLC. Updated: 2023-05-30